Bacteromic Sp. z o.o. is a part of the Scope Fluidics Group and was established to develop the BACTEROMIC system, used to assess the drug susceptibility of microorganisms. The BACTEROMIC system enables phenotypic evaluation of the efficacy of antibiotics, used to treat infections of the respiratory system, blood, urinary tract, skin, and other areas. It also has the capability to detect resistance mechanisms. Thanks to the determination and expertise of a multidisciplinary team of biotechnologists, engineers and software developers, and their innovative approach to modern diagnostics, this device holds significant market potential and the ability to revolutionize antibiotic treatment.
| Website | http://www.bacteromic.com |
| Employees | 49 (36 on RocketReach) |
| Founded | 2017 |
| Phone | +48 22 376 21 14 |
| Industry | Biotechnology Research |
| Competitors | Celltrion Healthcare Co.,Ltd., Zymeworks Inc., INOVIO Pharmaceuticals, Inc., Seres Therapeutics, Zymergen, Inc., BiomX Inc, Argonaut Manufacturing Services Inc., Elysium Health, MediSieve, AvidBiotics Corp. +34 more (view full list) |
Looking for a particular BacterOMIC employee's phone or email?
BacterOMIC Questions
Bernd Eberhardt is the CEO of BacterOMIC.
36 people are employed at BacterOMIC.
Top BacterOMIC Employees
-
25
-
Merel Broek-Kühbauch
VP Commercial at BacterOMIC
Utrecht, UT, NL3 -
Łukasz Richter
Head of Product at BacterOMIC
Warsaw, PL1
Related Companies
